Company Data

Kineta Inc.

Ticker
KA
Price Target
Refer to Report
Volume
602.4K
52wk Range
$0.3339 - $5.39
Advanced Market Data

Overview

Kineta Inc is a clinical-stage biotechnology company with a mission to develop next generation immunotherapies that transform patients’ lives. The company’s lead asset is KVA12.1, a VISTA blocking immunotherapy.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy